"GABAergic"代理人真的对GABA如此有选择性吗? 从麻醉剂的乱伦行为及其在体外的分子点对单位与多位点假设的含义
Kush M Kale1, Peter A Goldstein2,3,4, Jaideep J Pandit1,5
1From the Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
麻醉剂不仅限于单个分子点. 大多数麻醉剂与具有相似强度的多个目标相互作用,挑战其催眠作用的主导机制的想法.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 麻醉剂通常是由一个单一的主导分子标 (例如GABAergic,NMDAergic) 描述的.
- 赋予单一目标的理由不清楚,可能意味着单一的行动机制.
研究的目的:
- 为了调查麻醉剂是否在单个分子点上表现出明显的最高功效.
- 为了确定麻醉作用的常见描述是否与体外剂量反应数据一致.
主要方法:
- 对310项关于麻醉剂的体外研究数据的系统审查.
- 对剂量-反应关系的分析,以评估各种分子标的功效.
主要成果:
- 大多数麻醉剂都表现出高度的乱交性,与多个分子标相互作用,具有相似的强度.
- 普罗波在尼古丁受体和HCN通道上显示出比GABA-A受体更高的强度.
- 埃托米达,德克斯米多米丁和胺分别对GABA-A受体,α2-上腺素受体和NMDA受体表现出相对向特异性.
结论:
- 对于大多数麻醉剂来说,单一的主导分子标的概念很难基于体外数据来证明.
- 药剂和分子标的相互乱交支持了麻醉作用的多部位机制.
更多相关视频
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Dose-Response Relationship: Selectivity and Specificity
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
